Has Steven Savella, MD received payments from drug or device companies?

Yes. Drug and device makers reported $147 in general payments to Steven Savella, MD across 2 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Savella, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Savella, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Savella, MD

Cardiovascular Disease · Woodbury, NYNPI 1811212277

Payments from drug & device makers

$147in general payments, 2019–2025

Across 2 payments — averaging $73.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$120
Abbott$27

What the payments were for

Food & beverage$147100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	1	$120
Abbott	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RESONATE$120

How this compares

$147 in reported general payments places this provider in the 10th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024

$639,623

Medicare patients

2,805

Services billed

7,405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	413	$491,783
XareltoRivaroxaban	98	$133,324
EntrestoSacubitril/Valsartan	78	$117,838
Repatha SureclickEvolocumab	63	$51,960
OzempicSemaglutide	14	$22,811
FarxigaDapagliflozin Propanediol	21	$21,253
Praluent PenAlirocumab	21	$18,816
Metoprolol Succinate	906	$13,065
Atorvastatin Calcium	766	$7,994
NexletolBempedoic Acid	12	$7,985
Rosuvastatin Calcium	423	$5,436
Nebivolol Hcl	79	$5,385
Losartan Potassium	467	$4,781
Ezetimibe	133	$3,908
Amlodipine Besylate	633	$3,316

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Woodbury

James MinNew York$41.1M
Robert RosensonNew York$6.9M
Roxana MehranNew York$6.4M
Roger HajjarNew York$5.2M
Philippe GenereuxNew York$4.4M
Vijay IyerAmherst$4.3M
Gregg StoneNew York$3.7M
Szilard VorosStony Brook$3.7M
Valentin FusterNew York$2.9M
Sean DonahoeRiverhead$2.8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →